Avidity Biosciences Inc (RNA)
26.45
+0.87
(+3.40%)
USD |
NASDAQ |
May 03, 16:00
26.44
0.00 (0.00%)
After-Hours: 20:00
Avidity Biosciences Revenue (TTM): 9.56M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.56M |
| September 30, 2023 | 10.14M |
| June 30, 2023 | 9.80M |
| March 31, 2023 | 9.662M |
| December 31, 2022 | 9.224M |
| September 30, 2022 | 8.307M |
| June 30, 2022 | 7.988M |
| March 31, 2022 | 8.417M |
| Date | Value |
|---|---|
| December 31, 2021 | 9.326M |
| September 30, 2021 | 9.616M |
| June 30, 2021 | 9.199M |
| March 31, 2021 | 8.133M |
| December 31, 2020 | 6.787M |
| September 30, 2020 | 6.09M |
| June 30, 2020 | 4.994M |
| March 31, 2020 | 3.677M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
3.677M
Minimum
Mar 2020
10.14M
Maximum
Sep 2023
8.182M
Average
8.808M
Median
Revenue (TTM) Benchmarks
| Ironwood Pharmaceuticals Inc | 442.74M |
| Codexis Inc | 70.14M |
| Akoya Biosciences Inc | 96.63M |
| DocGo Inc | 624.29M |
| Kineta Inc | -- |